When you’re billing for Botox treatments for chronic migraines, you’re entering the realm of the most complicated area of medical billing. The combination of prior authorization requirements; exacting diagnosis criteria; and complexities related to billing for discarded medication provide numerous avenues to make a claim fail.
This article explains the ins and outs of coding 64615 as the procedure for injecting the Botox, and j0585 as the Botox itself.
Botox Billing for Chronic Migraine Codes
Both codes must be billed together on the same date to ensure every clean claim for a chronic migraine Botox treatment is paid.
Procedure code: 64615
The procedure code is for the actual process of injecting Botox. It is defined as chemodenervation of muscle(s), muscles innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (e.g., for chronic migraine) and is therefore defined as bilateral. Therefore, you must not add any modifier such as RT for right side or lt for left side to this code.
The standard preempt injection protocol includes 31 injection sites throughout the head and neck. The national average reimbursement for the procedure itself ranges from approximately $140 to $160 depending upon where you are practicing.
Drug code: j0585
The drug code is for the medication, which is injection, onabotulinumtoxina, 1 unit. For the standard chronic migraine protocol, you will bill for exactly 155 units. The majority of the claim is based upon the cost of the drug.
Under Medicare part b, administration code 64615 must be paired with medication code j0585 in order to obtain prior authorization. Any other pairings of medication with administration codes do not require prior authorization. However, because of Medicare’s regulatory rules surrounding migraine treatment, these are the only permitted pairings for prior authorization.
Similarly, under commercial insurance plans, the requirements for obtaining prior authorization are essentially identical. To receive authorization, you will need to submit supporting Documentation including Documentation establishing that the patient suffers from chronic migraine; Documentation demonstrating that the patient has previously attempted to utilize preventative medications to treat their migraines and those medications were ineffective; and Documentation evidencing the headache burden experienced by the patient (such as a headache diary).
Billing for discarded medicine
Botox is supplied in single-use vials containing either 100 units or 200 units. Using a standard 200 unit vial for a standard chronic migraine protocol results in 45 units being discarded. Although you can bill for the units discarded, you must use the modifier JW.
In addition to billing for the amount administered on line item #1 of the claim form, you must also bill separately for the units discarded on line item #2 of the claim form. You bill for discarded amounts with modifier JW added after the code number (i.e., j0585-JW x 45 units). Similarly, if you administer an entire vial (for example 100 units from a 100 unit vial), you would bill modifier jz indicating that there was zero waste (i.e., j0585-jz x 100 units).
Required supporting Documentation
Payers strictly enforce Documentation requirements for Botox claims. As a result of frequent audits, they understand that this is a costly treatment. Claims will be rejected if your Documentation does not contain all of the information requested below.
Documentation required for initial treatment
You must establish that the patient suffers from chronic migraine and has failed to respond to other forms of treatment prior to administering Botox to them for the first time. Please review your charts carefully and document the following:
- Documentation must reflect that the patient experiences headaches on 15 or more days per month for at least three consecutive months. Additionally, headaches must persist for at least four hours during each headache episode. This requirement must be met prior to initiating treatment with Botox.
- Each preventative medication prescribed to the patient must be documented with its corresponding dose, length of time taken, and reason why it failed to prevent future migraine episodes. Examples of reasons why a preventative medication fails could include ineffectiveness or intolerable side effects. You must document whether the medication failed due to ineffectiveness or adverse reactions.
- Documentation must demonstrate that migraines significantly impede daily activities, including work, education, and social relationships. Patients suffering from significant disability will need to complete validated tests assessing their level of disability resulting from migraines (such as midas).
- You must document that you discussed alternative methods of managing migraines (including behavioral therapies, physical therapy and/or lifestyle modifications) with your patients.
Documentation required for ongoing treatments
Once your patient has received multiple courses of Botox treatment and have established some degree of benefit from receiving these injections, Documentation requirements differ slightly from those associated with initial treatment. Specifically:
- You must document evidence that previous Botox injections resulted in measurable reductions in frequency/severity of headache episodes and improvements in functional ability relative to pre-treatment levels. Typically, it takes 2 cycles of treatment to see measurable efficacy.
- Your Documentation should include diagrams illustrating which sites were utilized for injections on each side of the patient’s head/face. Many Payers require Documentation of these types of diagrams. Providing diagrams labeled “cosmetic” is insufficient.
- Because Botox comes in single use vials (usually 100 units or 200 units), you must document how many units were used and how many were discarded. Even if you discarded zero units, it is essential to document this fact.
Chronic Migraine Reimbursements
Total payment for Botox treatment involves two elements: procedure fee (cpt 64615) and cost of Botox (j0585).
Procedure fee (cpt 64615)
Costs associated with performing the injection procedure are covered under cpt 64615. Based on relative value unit (rvu) calculations in 2026, the work rvu for cpt 64615 has decreased from 1.85 to 1.80 due to CMS’ efficiencies adjustment. The total rvu value associated with cpt 64615 is approximately 4.6 in 2026. Applying Medicare’s conversion factor of $33.4009 yields an estimated average national payment ranging from approximately $153-$154. This represents only the fee associated with performing the procedure.
Cost of Botox (j0585)
Botox costs represent substantially more than half of the total cost associated with treating patients who suffer from chronic migraines. The price of Botox per unit varies depending upon where you are located, since Medicare utilizes an ASP+6% pricing model. According to this pricing model, in 2026, Medicare will pay approximately $6.30 per unit of Botox. At this rate, treating a patient who requires 155 units would yield a reimbursement totaling approximately $975.
Combined total estimated payment
Combining procedure fees with costs associated with purchasing and providing Botox yields a total estimated payment range of $1100-$1200. Payments made by private insurers may exceed Medicare payments by as much as 200%.
Factors affecting payment
There are several factors affecting how much providers are reimbursed by Payers. Included among these are:
- Geographic practice cost indices adjust payment levels according to regional costs. Providers practicing in high-cost areas receive greater payments than providers practicing in low-cost areas (or vice versa).
- Office-based services incur higher practice expenses than hospital-based services. Therefore office-based services generate greater revenue than hospital-based services because offices absorb higher administrative costs.
- Commercial contract reimbursements typically involve multiplying Medicare Rates by a percentage that ranges anywhere from 120%-200%.
Acquisition model determines whether provider bills drug or pharmacy bills drug
Common Mistakes and How to Avoid Them
The best way to avoid denials is to know the most common mistakes and prevent them before they happen.
Incorrect Unit Billing
This is the most common cause of claim denial.
The rule is simple but easy to miss in a busy clinic: units billed must equal units delivered to the patient, not units drawn from the vial. Billing 1 unit instead of 155 units underpay the claim massively.
Billing 155 units when only 100 were administered is overbilling and creates audit risk.
How to avoid it: Verify the unit count on every claim before submission. The procedure note must match the claim line. If the note says 155 units and the claim says 100 units, the claim will deny.
Missing JW or JZ Modifiers
Since July 1, 2023, JW and JZ modifiers have been national CMS requirements. JW is used when there is wastage from a single-use vial. JZ is used when there is zero waste.
How to avoid it: Always include the correct modifier. If you discard medication, bill it on a separate line with JW appended. If you use the entire vial, bill JZ on the primary line. Missing either modifier results in CMS rejection.
Confusing 64615 with Other Procedure Codes
CPT 64615 is for bilateral chemodenervation for chronic migraine. Do not use 64612 for chronic migraine, as that code is for unilateral facial nerve conditions like blepharospasm. Do not bill individual injection codes like 64612 or 64616 alongside 64615 for the same session. The 64615 code bundles all the injection sites into one procedure.
How to avoid it: Train your billers to recognize the correct code for chronic migraine. Make it part of your coding workflow to verify that 64615 is the code being used.
Adding Anatomical Modifiers to 64615
Because 64615 is inherently bilateral, appending modifiers like RT, LT, or 50 is incorrect. The descriptor already states “bilateral.” If you append these modifiers, the claim will deny.
How to avoid it: Remove these modifiers from the claim. The modifier field for 64615 should be blank.
Billing Before Prior Authorization Is Approved
Most payers require prior authorization before the procedure is performed. If you do the treatment without authorization, the claim will deny. Prior authorization requirements include documented failure of at least two preventive medication classes and at least 15 headache days per month for at least three months.
How to avoid it: Verify the prior authorization status before submitting the claim. Obtain the authorization before the treatment. Keep a record of the authorization number.
Not Proving Medical Necessity
The diagnosis code alone is not enough. You need to document the headache frequency, duration, failed treatments, and disability. Payers will deny claims that do not have this documentation.
How to avoid it: Include all of the required documentation in the chart. Use a checklist to make sure nothing is missing before the claim goes out.
Billing for Follow-the-Pain Sites Without Documentation
The PREEMPT protocol allows up to 8 additional sites beyond the 31 fixed sites, bringing the total to 39 sites and 195 units. However, if the provider bills 195 units but the note only documents the 31 fixed sites, that is a recoupment scenario on post-payment review. Auditors want to see the sites listed.
How to avoid it: Document the actual injection sites used. Use a numbered list or a labeled diagram in the chart. The units delivered at each site must reconcile to the J0585 unit count on the claim.
Billing Too Early
Treatments are generally covered only once every 12 weeks. If you bill before the 12-week mark, the claim will deny.
How to avoid it: Track the date of the last treatment. Do not bill until at least 12 weeks have passed.
Not Documenting the Drug Information
Some payers require the NDC number and lot number on the claim. Missing this information can cause a denial.
How to avoid it: Document the NDC and lot number in the chart and include them on the claim where required.
Bottom Lines
Botox billing for chronic migraine is not just about picking the right codes. It is about documenting the patient’s condition, meeting the clinical criteria, obtaining prior authorization, and correctly billing for both the administered and discarded medication.
The two codes are straightforward. The complexity comes from everything else. Get those pieces right, and the claim will pay.
documenting failed treatments, and navigating payer requirements. Get those pieces right, and the claim will pay.
FAQs
Can I bill 64615 and J0585 on the same day?
Yes, clean claims must include both of these line items submitted on the same day. The procedure code 64615 is for the injection service, and the drug code J0585 is for the medication itself. You cannot bill one without the other.
How many units of Botox should I bill for chronic migraine?
For the standard PREEMPT protocol, bill exactly 155 units. Some patients may require more units based on clinical presentation, but the standard protocol uses 155 units. If you go over 155 units, make sure your documentation supports the additional units.
What should I do if I open a 200-unit vial but only use 155 units?
Bill the administered 155 units on one claim line and bill the discarded 45 units on a separate line with modifier JW attached. You must document the amount discarded in the medical record. Without documentation, the claim for discarded medication will be denied.
Does Medicare cover Botox for chronic migraine?
Yes, when specific medical criteria are met. Medicare Part B covers Botox for chronic migraine when the patient has 15 or more headache days per month, with at least 8 days being migraine-type headaches, and has failed other preventive treatments. Prior authorization is required.
How often can I bill for Botox treatments?
Treatments are generally covered only once every 12 weeks. The clinical trials for the PREEMPT protocol used a 12-week interval, and payers typically follow this schedule. Billing before the 12-week mark will result in a denial.
Need Help with Your Botox Billing?
Botox billing can be complicated, and denials are costly. If you are dealing with prior authorization delays, claim denials, or just want to make sure you are capturing every dollar you are owed, help is available.
UControl Billing handles the entire Botox billing process from start to finish. We verify patient eligibility, obtain prior authorizations, submit clean claims, and appeal denials when they happen. We know the payer requirements for Medicare and commercial plans, and we make sure your documentation meets the standards that auditors look for.
Stop leaving money on the table. Contact UControl Billing today for a free claims review. Let us show you how much more revenue your practice could be collecting.
